Skip to content

Alar Pharmaceuticals Inc Sustainability Reports

Alar Pharmaceuticals Inc. is a biopharmaceutical company engaged in the research, design, and development of long-acting release drug products. Its pipeline focuses primarily on innovative long-acting injectables for central nervous system disorders and chronic diseases, such as opioid use disorder and depression.

Sector: Manufacturing

Country: Taiwan

Exchange: Taipei Exchange

FIGI: BBG00XKGF2C5

2 reports from 2024 to 2024